M. Ozguroglu Et Al. , "Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Ozguroglu, M. Et Al. 2011. Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .
Ozguroglu, M., Oudard, S., Sartor, A. O., Hansen, S., Machiels, J. H., Shen, L., ... De Bono, J. S.(2011). Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
Ozguroglu, M. Et Al. "Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Ozguroglu, M. Et Al. "Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Ozguroglu, M. Et Al. (2011) . "Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
@article{article, author={M. Ozguroglu Et Al. }, title={Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}